mortality confer ence 報告者 : 呂淑偉大夫 指導者 : 麥淑珍主任. basic data name: sex:...
TRANSCRIPT
Mortality Conference
報告者 :呂淑偉大夫指導者 :麥淑珍主任
Basic Data
• Name:
• Sex: Female
• Age:12Y/O
Chief Complaint
• Conscious change with right limbs weakness since 6 days
Present Illness
• Relative well in the past• 89/11/21-11/24: intermittent fever• Since 11/24: irritable, confusion, crying• Since 11/26: unable to walk
--> other H, CT: negative --> MBD on 11/28• 11/29: conscious disturbance, Rt limbs weakness
--> our OPD --> admitted
Other History
• Birth Hx: G2P2, FT, BBW:3200gm, C/S• Past Hx: nil• Drug Hx: nil• Vaccine Hx: as schedule• Development: as milestones• Family Hx: non-contrubutory
no acute illness
Physical Examination
• GA: acute ill looking, no CP distress• V.S: BP: 134/83 mmHg, PR:96/min,RR:26/min,
BT:37.3C• Skin: no rash• HEENT: no oral ulcer, no throat injection• Neck: supple• Heart: RHB, no murmur• Chest: Clear BS
Physical Examination
• Abdomen: soft, no hepatosplenomegaly• Ext: freely movable, no ROM limitation• NE:
– C: confused with delirum– O: isocoric pupil with prompt LR– M: full MP, normal DTR– A: normal respiratory pattern– Crainal nerve: no special finding
Hospital Course• Day 1: --R/O encephalitis ---> LP: IICP: 370mmH2O,
WBC: 0, RBC:10; EBVCA IgG:1:1280, IgM(-) --> Glycetose,: Tegretol --> EEG: few focal spikes over P4
• Day 2-4: fever, still bizarre behavior, seizure at D3, acute urine retention
• Day 5: Rt lung pneumonia patchy
• Day 6: SOB -->ICU--> ETT intubation; PCN-->unasyn
• Day 8: frequent seizure --> lamictal
• Day 9, 14: extubation failure Paired EBV titer: IgG: 1:2560, IgM: (-)
• Day 15: dilantin ( status epilepticus)
• Day 18-20: fever, Rt lung white out, intractable seizure --> Abx: oxacillin + GM + erythromycin --> AEDs: dilantin, topamas, chloral hydrate
• Day 21--22: extubation, UGI bleeding
• Day 23--28:-- Re-intubation; Sputum: MRSA,GNB; -- Urine candida, sono: fugus ball => cefobid + targocid + fluconazole
• Day 29: tracheostomy
• Day 31: VPC: hold dilantin (normal dilantin level)
• Day 36: skin rash (erythema multiform) --> DC Abx --> solucortef + allermin
• Day 37: hepatomegaly: GOT/GPT:122/85
• Day 41: severe tarry stool --> cimeticine + transamin
• Day 42: urine /C: candia --> fluconazole=> fungizone
• Day 43--50: --Seizure: dilantin, haldol + akineton --Bleeding tendency ( PT, APTT prolonged) --DIC test (+), U/C: E.coli => unasyn + GM -- Jaundice, liver Bx: C/W Ac. Hepatitis
• Day 51: Brain MRI: brain atrophy
• Day 52--62: -- Polyuria, DI, electrolyte imbalance, VPC ( Na:152, S Osm:333, U SpGr:1.007)
• Day 63: -- Electrolyte got normal -- Episodic seizure with VPC, => subsided s/p chloral hydrate -- Sudden onst of Vf, pulseless, cyanosis on at 0:10 => CPR, defibrilation, lidocaine, epinephrine => Expired at 2:18 -- Na/ K/ Ca: 134/5.2/9.7, Glu: 248 ABG: desaturation, no acidosis initially Heart sono: no pericardial effusion
Lab data• WBC N/L Hgb Plt CRP
891201 6190 71/19 12.6 258k <0.01900113 5200 11.1 260k 900201 8220 8.7 261k
• Na K Ca BUN Cre GOT GPT Bil Alb891201 140 4.5 8.5 10900111 149 310 8.1/3.7 3.0 900121 151 3.5 8.8 26 0.9 80 7/3.1 900201 122 1.6 7.6 40 0.2/0 135 2.3 9.8 134 5.2 9.7
Lab Data
• Cultures – CSF virus/C: negative– Sputum (12/6): S. aureus
(12/24): MRSA, GNB ( 1/3): S. aureus (1/31): P. aeruginosa
– Urine (12/26): Candida albicans (1/3): E. coli (2/1): P. aeruginosa
• |-| fever illness |-------Conscious disturbance----------------| |----------------seizure-----------------------| |-------dilantin --| |-----| |-----------| ||-|----VPC----Vf-|| |---DI--| |------Pnuemonia, UTI------------------------|
Final Diagnosis
• Acute encephalitis with intractable seizureHighly suspect EBV encephalitis
• Arrhythmia (VPC, Vf) with cardiogenic shock• Central diabetes insipidus • Pneumonia with respiratory failure• UTI: candida, E.coli, P.aeruginosa• Acute hepatitis with jaundice• UGI bleeding
Cause of her death ? 1. EBV encephalitis
2. VPC and Vf
Epstein-Barr Virus
Epstein-Barr Virus
• a DNA virus
• Causes> 90% infectious mononucleosis• Humans: the only source (Infects >95% population)
Epstein-Barr Virus-- Diagnosis --
• Classic S/S of infectious mononucleosis– fever, pharyngitis, LAP, splenomegaly
• Hetrophil Ab(+)
• EBV-specific serology– Anti -VCA IgM: positive– Paired anti-VCA IgG
• 4X change in acute / convalescent stages
EBV--Complications of IM• Splenic rupture (2nd week, 0.2%)
• Airway impairment
• Neurologic involvement
• Hemolytic anemia, aplastic anemia
• Myocarditis (resolving in 3-4wks)
• Interstitial pneumonia (resolving in 3-4wks)
• Pancreatitis, parotitis, orchitis
• VAHS
EBV-- Neurologic involvement --
• Incidence: 5.5-18%• Manifestations
– Aseptic meningitis: fever, seizure, meningeal signs
– Encephalitis: fever, mental status change, ataxia bizarre movement, seizure, IICP signs
– Meningoencephalitis
– Alice in Wonderland syndrome: perceptual distortions of space/ size
– Transverse myelitis
– Guillian-Barre syndrome
– Cranial neuritis
Epstein-Barr Virus-- Neurologic involvement --
• Neurologic S&S– May precede, occur concomitantly or follow by
several weeks of IM– May be the first /only manifestations
EBV encephalitis and encephalomyelitis< Pediatr Radiol 1996 26:690-693>
• 29 Pt, 1-15 yr• Conscious disturbance (100%)
• Seizures (52%)
• Visual hallucination (41%)
• Acute psychosis (34%)
• Fever (31%)
• Hypersomni-insomnia (6%)
• Urinary retention (10%)
• Abducens palsy (10%)
• Facial palsy (10%)
• Ataxia (7%)
• Acute hemiparesis (7%)
• Transient visual loss (7%)
• Ptosis (7%)
• Auditory hallucination (7%)
• Choreoathetosis (7%)
• Hearing impairment (7%)
• Diplopia (3%)
• Nystagmus (3%)
• Custatory hallucination (3%)
Epstein-Barr Virus-- Treatment --
• Good supportive care
• Avoid contact sports (splenic rupture)
• Aggressive management of IICP
• Anticonvulsant for seizure
• Intravenous acyclovir – Decrease -- viral replication
-- oropharyngeal sheeding– No effect of -- severity of symptoms
-- eventual clinical course
Epstein-Barr Virus-- Prognosis --
• Majority: benign outcomes
• Persistent neurologic abnormalities– Incidence: 40%– Global impairment– Perseverative autistic-like behavior– Persistent extremitis paresis
Acute maninfestations and neurologic sewuelae of EBV encephalitis, Pediatr Infect Dis J, 1996; 15:871-5
Epstein-Barr Virus-- Mortality--
• CNS
• Heart
Epstein-Barr Virus-- Mortality (1)--
• Early report– Guillain-Barre syndrome / brain edema, herniation
• Recent report– Brainstem encephalitis
• 8M/O, drowsiness, fever, vomiting x 3 days-->8hr: gasping, comatous, LP:high pressure(400) lymphocyte pleocytosis--> Abx + acyclovir-->expired on day 16 from central faliure
• VCA IgG 4X change, Brain sono,, Brain CT
Fatal brainstem encephalitis caused by EBV, C.S.Chi, Pediatr Radiol 1994 24:596-597
Epstein-Barr Virus-- Mortality (2)--
• Acute encephalitis in primary EBV infection– 6 y/o girl, acute onset of IM-like syndrome
• D19: progressed to encephalitis, coma
• D27: death
• Acyclovir: did not improve
• Serology: primary EBV infection
Fatal acute encephalitis in primary EBV infectionArch-Fr-Pediatr. 1990 Aug-Sep’ 47(7):513-4
Epstein-Barr Virus-- Mortality (3)--
• Polyradiculomeningoencephalitis by EBV– 21y/o boy, encephalitis– Sudden drop of BP– Necropsy: moderate inflammatory infiltrations
in leptomeninges, atypical lymphoid cells– Heart arrest from acute autonomic neuropathy
Fortschr-Neurol-Psychiatr. 1984 Mar 52(3):73-82
Epstein-Barr Virus-- Mortality (4)--
• Fatal EBV myocarditis in repetitive myocarditis– 9y/o boy
– Previous 2 myocarditis: chicken pox; undetermined origin
– The fatal episode: seroloy --acute EBV infection• Autopsy: PCR for EBV (+) in heart & liver
• HLA-DR: DR4, DR13(+)< DR4: associated with autoimmune dz-- dilated cardiomyopathy>
– Postulate: aberrant immune response
Pediatr-Patho-Lab-Med. 1995 Sep-Oct;; 15(5):805-12
Epstein-Barr Virus-- Mortality (5)--
• 14 y/o girl (1977)– Atypical lymphocytosis, fever, sorethroat– Day 8: cardiopulmonary attest --> death
• Initial monitor: Vf
– Autopsy: myocardial mononuclear infiltrates
• 20 y/o – Hetrophil titer 1:448– Chest pain, EGK: RBBB, inverted T– Cardiac arrest
Epstein-Barr Virus-- Myocarditis--
• 38 y/o female– Viral syndrome, myagia, fever, malaise– Chest pain, SOB, near-syncope– EKG: AMI– Endomyocrdal biopsy: viral cause– EBVCA IgG: 1:640 --> 1:320
EBNA: 1:20---> 1:40
Southern-medical-journal 1989 Sep; 82(9): 1184-7
Ventricular arrhythmias
1. Premature QRS 4. Abnormal ST, T
2. Different QRS 5. No preceded p
3. Prolonged QRS duration
Bigeminy, Trigeminy, Couplets,Triplets
Premature ventricular contractions (PVCs)
PVCs -- Causes• Healthy children (50-70% on 24hr EKG)• LV false tendon (Purkinge fibers)• Myocarditis, myocardial injury, infarction• Cardiomyopathy (dilated, hypertrophic)• Cardiac tumor; MVP• RV dysplasia• Long QT syndrome (QTc>0.44sec)• CHD, acquired heart dz (pre-OP, post-OP)• Digitalis, drugs (catecholamines, theophylline,
caffeine, amphetamines, anesthetic agents)• Electrolyte imbalance (k, Ca, Mg)
PVCs -- Significance
• Associated underlying heart dz
• History of syncope, sudden death of family
• Precipitated by/ more frequent -- activity
• PVC with symptoms
• Multiform (esp. couplets)
• R on T phenomenon
• > 6 PVCs / one min
Multifocal PVCs
R on T
PVCs -- Treatment
• Symptomatic– Frequent PVCs
• IV bolus lidocaine 1mg/kg
• Maintain: 20-50ug/kg/min
– Cardiomyopathy, RV dysplasia-blockers (atenolol 1-2mg/kg, po, qd)
– Dilantin, mexiletine( avoid class IA, III: amiodarone)
Ventricular fibrillation : Vf
• Terminal arrhythmia --> ineffective circulation
• Bizarre QRS, varying sized /onfiguration, rate: rapid / irregular
Vf -- Causes
• Postoperative state
• Severe hypoxia
• Hyperkalemia
• Digitalis or quinidine toxicity
• Myocarditis
• Myocardial infarction
• Drugs (catecholamines, anesthetics)
• |----------------seizure-----------------------|
|-------dilantin --| |-----| |-----------| |-----| midazolam |--| |-----| (BPCO,arrest)
|---------| Tegretol (AV block,arrhythmia,hypotension)
(1st AV block) |------| Lamictal hadol |------------------| (palpitation) Topiramate |------------| |----Chloral hydrate---------------------| ||-|----VPC----Vf-||
Hypotension, arrhythmiea, Vf
Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular
Care
• Pediatric Advanced Life Support
VF/pulseless VT
• Defibrillation– Up to 3 times if needed– 2-->4-->4J/kg
• Epinephrine– IV/IV: 0.01mg/kg
(1:10000; 0.1mg/kg)– ETT: 0.1mg/kg
(1:1000;0.1mg/kg)
*Attempt - ETT, vascular access*Give - Epi, q3-5mins*Consider - Vasopressors - Antiarrhythmics - Buffers*Identify & Tx - Hypoxemia - Hypovolemia - Hypothermia - Hypo/ Hyper-K - Tamponade - Tension pneumothorax - Toxins/poisons/drugs - Thromboembolism
• Attempt defibrillation 4J/kg(within 30-60 secs after each medication)– CPR-drug-shock (repeat)– CPR-drug-shock-shock-shock (repeat)
• Antiarrhythmic– Amiodarone: 5mg/kg bolus IV/IO– Lidocaine: 1mg/kg bolus– Magnesium: 25-50 mg (max:2g)
( torsades de pointes or hypomagnesemia)
• Attempt defibrillation with 4J/kg(within 30-60 seconds after each medication)– CPR-drug-shock (repeat)– CPR-drug-shock-shock-shock (repeat)
神未曾應許 :天色常藍 ,人生的路途花香常漫 ;
神未曾應許 :常晴無雨 ,常樂無痛苦 ,常安無虞 .
神卻曾應許 :生活有力 ,行路有光亮 ,作工得息 ,
試煉得恩助 ,危難有賴 ,無限的體諒 ,不死的愛 .